Solid state 13C NMR spectroscopy provides direct evidence for reaction between ethinyl estradiol and a silicone elastomer vaginal ring drug delivery system

被引:13
作者
McCoy, Clare F. [1 ]
Apperley, David C. [2 ]
Variano, Bruce [3 ]
Sussman, Heather [3 ]
Loeven, Daniel [3 ]
Boyd, Peter [1 ]
Malcolm, R. Karl [1 ]
机构
[1] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland
[2] Univ Durham, EPSRC Natl Solid State NMR Serv, Durham DH1 3LE, England
[3] Populat Council, One Dag Hammarskjold Plaza, New York, NY 10017 USA
关键词
Covalent binding; 17; alpha-Ethinyl-estradiol; C-13-labelled; Addition cure silicone elastomer; Nuclear magnetic resonance; Hydrosilylation; FEMALE CONTRACEPTION; INTRAVAGINAL RING; HIV PREVENTION; ESTROGEN-FREE; WOMEN; LEVONORGESTREL; DAPIVIRINE; SAFETY; PHARMACOKINETICS; ACETATE;
D O I
10.1016/j.ijpharm.2018.07.040
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Steroid molecules have a long history of incorporation into silicone elastomer materials for controlled release drug delivery applications. Previously, based on in vitro release testing and drug content analysis, we demonstrated indirectly that the contraceptive progestin levonorgestrel (LNG) chemically and irreversibly binds to addition cure silicone elastomers, presumably via a hydrosilylation reaction between the levonorgestrel ethynyl group and the hydrosilane groups in the poly(dimethylsiloxane-co-methylhydrosiloxane) crosslinker of the silicone elastomer. Here, for the first time, we report that solid state C-13 nuclear magnetic resonance (NMR) spectroscopy provides direct evidence for the irreversible binding of ethinyl estradiol (EE) - an estrogenic steroid molecule also containing an ethynyl functional group - to an addition cure silicone elastomer. By preparing silicone elastomer samples containing C-13-labelled EE, signals in the NMR spectra could readily be assigned to both the free and bound EE. Additional depolymerisation studies, performed on an addition cure silicone elastomer system from which the unbound EE fraction was completely extracted, further confirmed the presence of bound EE through the formation of coloured reaction mixtures resulting from the reaction of bound EE and trifluoroacetic acid (TFA). These methods will be particularly useful in the ongoing development of new steroid-releasing silicone drug delivery devices, including various vaginal ring devices for contraception, HIV prevention and multipurpose prevention technology applications.
引用
收藏
页码:689 / 697
页数:9
相关论文
共 45 条
[1]   Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms [J].
Al-Azzawi, F ;
Buckler, HM .
CLIMACTERIC, 2003, 6 (02) :118-127
[2]   Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women [J].
Baeten, J. M. ;
Palanee-Phillips, T. ;
Brown, E. R. ;
Schwartz, K. ;
Soto-Torres, L. E. ;
Govender, V. ;
Mgodi, N. M. ;
Kiweewa, F. Matovu ;
Nair, G. ;
Mhlanga, F. ;
Siva, S. ;
Bekker, L. -G. ;
Jeenarain, N. ;
Gaffoor, Z. ;
Martinson, F. ;
Makanani, B. ;
Pather, A. ;
Naidoo, L. ;
Husnik, M. ;
Richardson, B. A. ;
Parikh, U. M. ;
Mellors, J. W. ;
Marzinke, M. A. ;
Hendrix, C. W. ;
van der Straten, A. ;
Ramjee, G. ;
Chirenje, Z. M. ;
Nakabiito, C. ;
Taha, T. E. ;
Jones, J. ;
Mayo, A. ;
Scheckter, R. ;
Berthiaume, J. ;
Livant, E. ;
Jacobson, C. ;
Ndase, P. ;
White, R. ;
Patterson, K. ;
Germuga, D. ;
Galaska, B. ;
Bunge, K. ;
Singh, D. ;
Szydlo, D. W. ;
Montgomery, E. T. ;
Mensch, B. S. ;
Torjesen, K. ;
Grossman, C. I. ;
Chakhtoura, N. ;
Nel, A. ;
Rosenberg, Z. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) :2121-2132
[3]   Vaginal rings for menopausal symptom relief [J].
Ballagh, SA .
DRUGS & AGING, 2004, 21 (12) :757-766
[4]   The use of 13C labeling to enhance the sensitivity of 13C solid-state CPMAS NMR to study polymorphism in low dose solid formulations [J].
Booy, KJ ;
Wiegerinck, P ;
Vader, J ;
Kaspersen, F ;
Lambregts, D ;
Vromans, H ;
Kellenbach, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (02) :458-463
[5]   Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel [J].
Boyd, Peter ;
Fetherston, Susan M. ;
McCoy, Clare F. ;
Major, Ian ;
Murphy, Diarmaid J. ;
Kumar, Sandeep ;
Holt, Jonathon ;
Brimer, Andrew ;
Blanda, Wendy ;
Devlin, Brid ;
Malcolm, R. Karl .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 511 (01) :619-629
[6]   Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women [J].
Brache, Vivian ;
Sitruk-Ware, Regine ;
Williams, Alistair ;
Blithe, Diana ;
Croxatto, Horacio ;
Kumar, Narender ;
Kumar, Sushma ;
Tsong, Yun-Yen ;
Sivin, Irving ;
Nath, Anita ;
Sussman, Heather ;
Cochon, Leila ;
Jose Miranda, Maria ;
Reyes, Veronica ;
Faundes, Anibal ;
Mishell, Daniel, Jr. .
CONTRACEPTION, 2012, 85 (05) :480-488
[7]  
Buckler H, 2003, BJOG-INT J OBSTET GY, V110, P753, DOI 10.1111/j.1471-0528.2003.02408.x
[8]   Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial [J].
Chen, Beatrice A. ;
Panther, Lori ;
Marzinke, Mark A. ;
Hendrix, Craig W. ;
Hoesley, Craig J. ;
van der Straten, Ariane ;
Husnik, Marla J. ;
Soto-Torres, Lydia ;
Nel, Annalene ;
Johnson, Sherri ;
Richardson-Harman, Nicola ;
Rabe, Lorna K. ;
Dezzutti, Charlene S. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (03) :242-249
[9]   Feasibility study of Nestorone®-ethinylestradiol vaginal contraceptive ring for emergency contraception [J].
Croxatto, HB ;
Brache, V ;
Massai, R ;
Alvarez, F ;
Forcelledo, ML ;
Pavez, M ;
Cochon, L ;
Salvatierra, AM ;
Faundes, A .
CONTRACEPTION, 2006, 73 (01) :46-52
[10]   Progestin implants for female contraception [J].
Croxatto, HB .
CONTRACEPTION, 2002, 65 (01) :15-19